SCHEMBL2098683

SCHEMBL2098683

CCOP(=O)(CN(c1cccc2c(C(=N)NO)cccc12)S(=O)(=O)c1cc(Cl)cc(Cl)c1)OCC

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KEAP1 Q14145 4/20 0.33
NFE2L2 Q16236 4/20 0.33
ACLY P53396 2/20 0.32
MMP9 P14780 3/20 0.31
MMP1 P03956 1/20 0.31
ALDH1A1 P00352 1/20 0.31
THRB P10828 1/20 0.31
HPGD P15428 1/20 0.31
L3MBTL1 Q9Y468 1/20 0.31
MMP13 P45452 2/20 0.31
S1PR1 P21453 1/20 0.31
HCRTR2 O43614 1/20 0.31
PTGER1 P34995 1/20 0.30
HDAC3 O15379 1/20 0.30
HDAC11 Q96DB2 1/20 0.30
HDAC8 Q9BY41 1/20 0.30
HDAC6 Q9UBN7 1/20 0.30
HTT P42858 1/20 0.30
PSEN1 P49768 1/20 0.30
PSEN2 P49810 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2055342 0.84 KEAP1 (0.33) KEAP1NFE2L2ACLYS1PR1HCRTR2
SCHEMBL2055357 0.83 KDM4E (0.40) KEAP1NFE2L2ACLYALDH1A1THRB
SCHEMBL2055356 0.83 NSD2 (0.43) ALDH1A1THRBHPGDPTGER1HTT
SCHEMBL2098098 0.83 HPGD (0.32) MMP9MMP1ALDH1A1THRBHPGD
SCHEMBL13905580 0.83 S1PR1 (0.35) KEAP1NFE2L2ACLYL3MBTL1S1PR1
SCHEMBL2055352 0.81 LMNA (0.45) ALDH1A1HPGDL3MBTL1HTT
SCHEMBL2055380 0.81 KEAP1 (0.38) KEAP1NFE2L2ALDH1A1THRBHPGD
SCHEMBL2099895 0.81 TP53 (0.41) KEAP1NFE2L2ACLYALDH1A1THRB
SCHEMBL2055367 0.80 HTT (0.40) KEAP1NFE2L2ACLYALDH1A1L3MBTL1
SCHEMBL2055360 0.80 CTSG (0.39) KEAP1NFE2L2ACLYMMP9MMP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8163911-B2 Arylsulfonylaminomethylphosphonic acid derivatives, the preparation thereof and the use thereof as pharmaceutical compositions BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2012-04-24 US disclosed
US-20100261677-A1 ARYLSULFONYLAMINOMETHYLPHOSPHONIC ACID DERIVATIVES, THE PREPARATION THEREOF AND THE USE THEREOF AS PHARMACEUTICAL COMPOSITIONS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2010-10-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100261677-A1 ARYLSULFONYLAMINOMETHYLPHOSPHONIC ACID DERIVATIVES, THE PREPARATION THEREOF AND THE USE THEREOF AS PHARMACEUTICAL COMPOSITIONS ARSA, SULT2A1, PMM2 KEAP1 3301/4885NFE2L2 2068/4885ACLY 633/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.